 SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., Oct. 31, 2022 GLOBE NEWSWIRE -- Zai Lab Limited NASDAQ: ZLAB; HKEX: 9688, a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced that management from Zai Lab will participate in the following investor conferences in November: 